Coeptis Therapeutics, Inc.
USD16.40
+0.00 (+0.00%)
CEO
David Mehalick
IPO Date
2020-12-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$16.23
Prev. Close
$16.40
Day Low
$16.16
Day High
$16.99
52W Low
$6.80
52W High
$21.41
Market Cap
$0.06B
Volume
0.11M
| 12,500 |
| $0.00 |
| 13 Feb 2026 | Cogley Brian | Chief Financial Officer | M-Exempt | Acquired | 10,000 | $10.56 |
| 13 Feb 2026 | Deschamps Philippe | director | M-Exempt | Acquired | 5,700 | $10.56 |
| 13 Feb 2026 | Deschamps Philippe | director | A-Award | Acquired | 3,250 | $0.00 |
| 13 Feb 2026 | Calise Chris | director | A-Award | Acquired | 3,250 | $0.00 |
| 13 Feb 2026 | Calise Chris | director | M-Exempt | Acquired | 5,700 | $10.56 |
| 13 Feb 2026 | Mehalick David | director, 10 percent owner, officer: CEO and President | M-Exempt | Acquired | 148,875 | $7.05 |
| 13 Feb 2026 | Mehalick David | director, 10 percent owner, officer: CEO and President | A-Award | Acquired | 51,250 | $0.00 |
| 13 Feb 2026 | Cochran Christopher P. | director | M-Exempt | Acquired | 5,700 | $10.56 |